Dabrafenib and/or Trametinib Rollover Study
Novartis
Novartis
Travera Inc
Pfizer
Pfizer
Obsidian Therapeutics, Inc.
Pfizer
Filamon LTD
ViroMissile, Inc.
Replimune, Inc.
Tizona Therapeutics, Inc
Daiichi Sankyo
Natera, Inc.
Second Life Therapeutics
AgonOx, Inc.
Novartis
Elephas
Inhibrx Biosciences, Inc
Degron Therapeutics Co.
AstraZeneca
Revolution Medicines, Inc.
Tempus AI
Massive Bio, Inc.
Guangzhou FineImmune Biotechnology Co., LTD.
Incyte Corporation
Delfi Diagnostics Inc.
Marengo Therapeutics, Inc.
Tempus AI
Revolution Medicines, Inc.
Novartis
Labcorp Corporation of America Holdings, Inc
Checkpoint Therapeutics, Inc.
Taproot Health
ABM Therapeutics Corporation
Iovance Biotherapeutics, Inc.
VitaMed Research LLC
Inhibrx Biosciences, Inc
iTeos Therapeutics
Bristol-Myers Squibb
Sanguine Biosciences
Celldex Therapeutics
R-Pharm
NextCure, Inc.
AO GENERIUM
Convalife (Shanghai) Co., Ltd.
Apexigen America, Inc.
Fate Therapeutics
Klus Pharma Inc.
Shanghai Yunying Medical Technology
Cantargia AB
Kineta Inc.